Product Information
PHENTERMINE 37.5 MG TABLET is a generic product labeled by TAGI Pharma Inc., priced at $0.0762 per EA under NDC 51224010170. Its NADAC has been published 573 times since Nov 28, 2013.
Strength
37.5 mg/1
Manufacturer
TAGI Pharma Inc.NDC
51224010170
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
10/23/2024
Active Ingredients
PHENTERMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA200272On Market Since
3/8/2011
Pharmacological Classes
Price Statistics
The NADAC for PHENTERMINE 37.5 MG TABLET has been published 573 times since Nov 28, 2013, and over the history we have for it it has declined 27.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0762 per EA |
|---|---|
| All-time high | $0.1304 (Apr 16, 2014) |
| All-time low | $0.0546 (Apr 17, 2024) |
| Median price | $0.0922 |
| Average price | $0.0951 |
| Largest weekly change | +51.9% (Jun 19, 2024) |
| Weeks tracked | 573 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PHENTERMINE 37.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PHENTERMINE 37.5 MG TABLET, manufactured by TAGI Pharma Inc., is $0.0762 per EA (NDC 51224010170), effective Nov 13, 2024.
How has the price of PHENTERMINE 37.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for PHENTERMINE 37.5 MG TABLET has declined 27.9%. It has been tracked across 573 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PHENTERMINE 37.5 MG TABLET?
Since Nov 28, 2013, the NADAC for PHENTERMINE 37.5 MG TABLET has ranged from a low of $0.0546 (Apr 17, 2024) to a high of $0.1304 (Apr 16, 2014), with a median of $0.0922 per EA.
Are there cheaper alternatives to PHENTERMINE 37.5 MG TABLET?
Yes. 7 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, PHENTERMINE 37.5 MG TABLET, is $0.0697 per EA — about 9% below PHENTERMINE 37.5 MG TABLET.
Who manufactures PHENTERMINE 37.5 MG TABLET?
PHENTERMINE 37.5 MG TABLET (NDC 51224010170) is labeled by TAGI Pharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification